Design and results of phase I cancer clinical trials: three-year experience at M.D. Anderson Cancer Center. Efficacy and toxicity are both important outcomes in cancer clinical trials. Nonetheless, ...

Finding a convincing explanation of a complex issue is no easy task. The decision about what qualifies as the "best" solution is inevitably subject to biases and approximations. Coupling statistics ...

There are many ways to optimize one’s betting strategy. One of them is starting to work with statistical data. It can provide you with insight that can guide you towards more accurate predictions.

Multiplicity, or the use of many comparisons in a clinical trial, increases the likelihood that a chance association could be deemed causal. This problem commonly arises in clinical trials that have ...

14 November 2007 Doha- The Qatar Statistics Authority (QSA) will organize a one-day workshop on November 28 to discuss the draft project of the National Strategy for the Development of Statistics ...

Appointments strengthen late-stage clinical execution and statistical leadership as the Company advances multiple registration-directed programs in gastrointestinal cancers Mr. McAdory will oversee ...

Muscat – The National Centre for Statistics and Information (NCSI) has launched the National Strategy for Statistics and Information 2025–2030, marking a major step towards enhancing data-driven ...

Show More Department of Biomathematics, University of Texas M.D. Anderson Cancer Center, Houston 77030, USA. Efficacy and toxicity are both important outcomes in cancer clinical trials. Nonetheless, ...